Abstract:Breast cancer is one of the leading cancer types in women, which poses a high burden on health systems across the globe. Among the subtypes of breast cancer, triple-negative 4TI breast tumor has been reported as the most aggressive cancers, which have a high mortality and morbidity rates. [ 1 , 2 ] Due to the high drug resistance, higher chances of recurrence, poor prognosis, and great risk of metastasis, current treatment options such as surgery and chemotherapy available for triple-negative breast cancer, [ 1 ] are not very promising and effective. Therefore, new technologies are required to be applied for better treatment of triple-negative breast cancer. One of the most effective treatment options can be the use of nano-platform for drug delivery. These nanoplatforms can help in effective combinational therapeutic strategies. [ 3 , 4 ] To select the most suitable option, it is necessary to confirm the nature and characteristics of nanomaterials therefore, in the case of triple-negative breast cancer, metal nano-platforms can be of great importance such as using iron oxide (Fe 3 O 4 ) with various coatings, considering their importance such as high loading capacity, biocompatibility, imaging capability, controlled catalytic activities, multimodal cancer treatment, feasible production, and target specific delivery. [ 5–10 ] However, magnetic nanoparticles face a number of challenges, including uneven size distribution, limited drug loading, the use of hazardous chemical compounds in manufacturing, slow degradation with high agglomeration, and accumulation in vital organs with serious consequences. According to a number of studies, adding metal-organic frameworks (MOF) coatings on metal nano-platforms increases their porosity and functionality while also allowing for regulated drug release in an acidic environment. [ 11–16 ] Additionally, MOF coating improves the nano-platforms' biocompatibility, catalytic activity, and colloidal stability. [ 17–21 ] In addition to increasing the stability of the drug and enhancing its permeability in cell lines related to triple-negative breast cancer, Chowdhuri et al [ 22 ] and Alijani et al [ 23 ] used nanoplatforms by using different cell lines and found that using M@IRMOF-3/folic acid in NIH3T3 and HUVEC cells has greater biocompatibility and thus can be used as a potential treatment option. Moreover, M@MOF-doxorubicin (Dox)-carbon-aptamer and arene-based metal complexes were also used against triple-negative breast cancer. [ 2 ] It is now widely being studied that hyperthermia if combined with chemotherapy may increase the permeability of drugs as well as enhance the controlled release of Dox (drugs). In this regard, Chen et al [ 24 ] demonstrated that a nanoplatform known as M@poly[dopamine]@ZIF-90/Dox showed higher effectiveness and thereby inhibited the development and proliferation of cancer cells as compared to free drugs. Moreover, Xiang et al [ 25 ] treated breast cancer mice model with M@C-poly[vinylpyrrolidone] @Dox and found that this nanomaterial was more effective as compared to free Dox and thus significantly reduced the tumor size mediated by controlled pH-sensitive drug release. It also reduced drug toxicity in other organs and tissues, and increased biocompatibility as compared to the use of free Dox for the same purpose. Photodynamic therapy in combination with chemotherapy can kill tumor cells through the utilization of single oxygen molecules ( 1 O 2 ) and thus can restrict the growth of cancer cells further. Hence, this combinational therapeutic option can be more effective against triple-negative breast cancer cells as well as effectively overcome hypoxia as compared to the therapeutic option with a single modality approach. For example, Pandey et al [ 26 ] and Zhang et al [ 27 ] via a combination of chemotherapy with PDT enabled by Fe-TBP and PFTBA@HSA-DVDM@PM nano-platforms, respectively, were able to inhibit the proliferation of colorectal and breast malignancies up to 70% and 90% mediated by boosting the generation of 1 O 2 in tumor tissues. However, their findings suggest that the O 2 supply in malignant tissues is insufficient to generate a significant amount of 1 O 2 . While using MOF-coated nano-platforms, it remains impra -Abstract Truncated-

Oxygen-rich chemotherapy via modified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer.

The Oxygen-Generating Calcium Peroxide-Modified Magnetic Nanoparticles Attenuate Hypoxia-Induced Chemoresistance in Triple-Negative Breast Cancer

Facile Deposition of Manganese Dioxide to Albumin-Bound Paclitaxel Nanoparticles for Modulation of Hypoxic Tumor Microenvironment to Improve Chemoradiation Therapy.

Chemo–immunotherapy for chemo-resistance and metastasis of triple-negative breast cancer by combination of iron-oxide nanoparticles and dual-targeting doxorubicin liposomes

Mitochondrial Targeted Drug Delivery Combined with Manganese Catalyzed Fenton Reaction for the Treatment of Breast Cancer.

Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapy

Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release

Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma

Biguanide-anchored albumin-based nanoplatform inhibits epithelial-mesenchymal transition and reduces the stemness phenotype for metastatic cancer therapy

Abstract C016: Oxidative Phosphorylation is a Metabolic Vulnerability in Chemotherapy Resistant Triple Negative Breast Cancer

Triple-negative breast cancer treatment with core-shell Magnetic@Platinium-Metal organic framework/epirubicin nano-platforms for chemo-photodynamic based combinational therapy: A review

Albumin-bound paclitaxel for treatment of patients with refractory metastatic breast cancer

Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.

Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody

Therapeutic Efficacy of Oxaliplatin and Pembrolizumab Combination Treatment for Triple-Negative Breast Cancer

Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy

Paclitaxel/Tetrandrine Coloaded Nanoparticles Effectively Promote The Apoptosis Of Gastric Cancer Cells Based On "Oxidation Therapy"

Ferroptosis-enhanced Chemotherapy for Triple-Negative Breast Cancer with Magnetic Composite Nanoparticles.

[Study of Bioequiavailability of Paclitaxel for Injection (albumin Bound) and Abraxane and the Efficacy of Extension Treatments in Patients with Metastatic Breast Cancer].

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance

Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor